Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics (PRQR) Long-Term Investments (2021 - 2023)

Historic Long-Term Investments for ProQR Therapeutics (PRQR) over the last 3 years, with Q2 2023 value amounting to $676222.0.

  • ProQR Therapeutics' Long-Term Investments rose 204.93% to $676222.0 in Q2 2023 from the same period last year, while for Jun 2023 it was $676222.0, marking a year-over-year increase of 204.93%. This contributed to the annual value of $633573.6 for FY2022, which is 659231.79% up from last year.
  • ProQR Therapeutics' Long-Term Investments amounted to $676222.0 in Q2 2023, which was up 204.93% from $666545.3 recorded in Q1 2023.
  • ProQR Therapeutics' 5-year Long-Term Investments high stood at $747852.6 for Q2 2021, and its period low was $749.07 during Q1 2021.
  • Over the past 3 years, ProQR Therapeutics' median Long-Term Investments value was $664593.7 (recorded in 2023), while the average stood at $545218.4.
  • Over the last 5 years, ProQR Therapeutics' Long-Term Investments had its largest YoY gain of 9294461.27% in 2022, and its largest YoY loss of 1450.14% in 2022.
  • Over the past 3 years, ProQR Therapeutics' Long-Term Investments (Quarter) stood at $9151.8 in 2021, then surged by 6822.96% to $633573.6 in 2022, then rose by 6.73% to $676222.0 in 2023.
  • Its last three reported values are $676222.0 in Q2 2023, $666545.3 for Q1 2023, and $633573.6 during Q4 2022.